Macromolecules, Vol. 38, No. 10, 2005
Fluorene-alt-carbazole Copolymers 4075
PFCzIrPiq2. 2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lan-2-yl)-9,9-dioctylfluorene (12) (642 mg, 1.0 mmol), 3,6-
dibromo-9-(iridium(III)bis(1-phenylisoquinoline-N,C2′))-14-tri-
fluoro-11,13-tetradecyldiketone)carbazole (8a) (48 mg, 0.04
mmol), and 3,6-dibromo-9-hexanecarbazole (9) (402 mg, 0.96
mmol) were used in the polymerization. 1H NMR (CDCl3) δ
(ppm): 8.52 (s, 2H), 7.85 (t, 2H), 7.78 (d, 2H) (fluorene ring),
7.75 (d, 2H), 7.53 (m, 2H), 7.25 (s, 2H) (carbazole ring), 4.41
(s, 2H, N-CH2), 2.16 (t, 2H), 1.97 (d, 4H), 1.51-1.10 (m, 20),
0.93-0.77 (m, 16H) (aliphatic). 13C NMR (CDCl3) δ (ppm):
151.72, 140.87, 140.42, 139.58, 133.12, 126.18, 125.55, 123.66,
121.69, 119.89, 118.97, 109.06 (fluorene and carbazole ring),
55.37 (C9-fluorene ring), 43.43, 40.65, 31.81, 31.65, 30.12,
29.26, 29.08, 27.04, 23.92, 22.61, 14.03 (aliphatic). Anal. Calcd
for (C29H40)50(C18H19N)48(C56H47N3F3O2Ir)2: C, 87.07; H, 8.99;
N, 2.26. Found: C, 87.20; H, 9.29; N, 1.92.
PFCzIrNapy05. 2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lan-2-yl)-9,9-dioctylfluorene (12) (1.0 mmol), 3,6-dibromo-9-
hexanecarbazole (9) (0.99 mmol), and 3,6-dibromo-9-(iridium-
(III)bis(2-(1′-naphthylpyridine-N,C2′))-9-(14-trifluoro-11,13-
tetradecyldiketone)carbazole (8b) (0.01 mmol) were used in
the polymerization. 1H NMR (CDCl3) δ (ppm): 8.52 (s, 2H),
7.84 (d, 2H), 7.78 (t, 2H) (fluorene ring), 7.74 (t, 2H), 7.52 (d,
2H), 7.24 (s, 2H) (carbazole ring), 4.39 (s, 2H, N-CH2), 2.16
(t, 2H), 1.97 (m, 4H), 1.58-1.09 (m, 20H), 0.92-0.76 (m, 16H)
(aliphatic). 13C NMR (CDCl3) δ (ppm): 151.71, 140.86, 140.42,
139.57, 133.11, 126.17, 125.54, 123.65, 121.69, 119.91, 118.97,
109.06 (fluorene and carbazole ring), 55.37 (C9-fluorene ring),
40.65, 31.81, 31.65, 30.12, 29.26, 29.08, 27.04, 23.92, 22.61,
109.06 (fluorene and carbazole ring), 55.37 (C9-fluorene ring),
43.42, 40.65, 31.81, 31.65, 30.12, 29.25, 29.08, 27.04, 23.92,
22.61, 14.03 (aliphatic). Anal. Calcd for (C29H40)50(C18H19N)49.5
(C56H47N3F3O2Ir)0.5 C, 88.16; H, 9.19; N, 2.21. Found: C,
87.56; H, 9.40; N, 1.75.
-
:
PFCzIrPhq1. 2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lan-2-yl)-9,9-dioctylfluorene (12) (0.50 mmol), 3,6-dibromo-9-
hexanecarbazole (9) (0.49 mmol), and 3,6-dibromo-9-(iridium-
(III)bis(2-phenylquinoline-N,C2′))-14-trifluoro-11,13-tetradec-
yldiketone)carbazole (8c) (0.01 mmol) were used in this
1
polymerization. H NMR (CDCl3) δ (ppm): 8.52 (s, 2H), 7.87
(t, 2H), 7.79 (m, 2H) (fluorene ring), 7.75 (d, 2H), 7.55 (t, 2H),
7.25 (s, 2H) (carbazole ring), 4.41 (s, 2H, N-CH2), 2.17 (t, 2H),
1.97 (t, 4H), 1.48-1.14 (m, 20H), 0.93-0.77 (m, 16H) (ali-
phatic). 13C NMR (CDCl3) δ (ppm): 151.72, 140.87, 140.43,
139.58, 133.12, 126.18, 125.56, 123.66, 121.71, 119.91, 118.97,
109.06 (fluorene and carbazole ring), 55.37 (C9-fluorene ring),
43.41, 40.66, 31.82, 31.66, 30.13, 29.26, 29.08, 27.04, 23.93,
22.61, 14.04 (aliphatic). Anal. Calcd for (C29H40)50(C18H19N)49-
(C56H47N3F3O2Ir)1: C, 87.78; H, 9.12; N, 2.23. Found: C, 87.20;
H, 9.24; N, 1.69.
PFCzIrPhq2. 2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lan-2-yl)-9,9-dioctylfluorene (12) (0.50 mmol), 3,6-dibromo-9-
hexanecarbazole (9) (0.48 mmol), and 3,6-dibromo-9-(iridium-
(III)bis(2-phenylquinoline-N,C2′))-14-trifluoro-11,13-tetradec-
yldiketone)carbazole (8c) (0.02 mmol) were used in this
1
polymerization. H NMR (CDCl3) δ (ppm): 8.85 (s, 2H), 7.87
(d, 2H), 7.79 (d, 2H) (fluorene ring), 7.75 (d, 2H), 7.56 (d, 2H),
7.26 (s, 2H) (carbazole ring), 4.23 (s, 2H, N-CH2), 2.15 (t, 2H),
1.92 (t, 4H), 1.55-1.14 (m, 20H), 0.93-0.77 (m, 16H) (ali-
phatic). 13C NMR (CDCl3) δ (ppm): 151.69, 140.82, 140.40,
139.55, 133.09, 126.15, 125.54, 123.63, 121.67, 119.87, 118.95,
109.04 (fluorene and carbazole ring), 55.34 (C9-fluorene ring),
40.62, 31.79, 31.63, 30.10, 29.23, 29.06, 27.02, 23.90, 22.58,
14.01 (aliphatic). Anal. Calcd for (C29H40)50(C18H19N)48(C56H47-
N3F3O2Ir)2: C, 87.07; H, 8.99; N, 2.26. Found: C, 87.28; H,
9.34; N, 1.94.
14.04 (aliphatic). Anal. Calcd for (C29H40
)
50(C18H19N)49.5
-
(C56H47N3F3O2Ir)0.5
: C, 88.16; H, 9.19; N, 2.21. Found: C,
87.78; H, 8.85; N, 1.60.
PFCzIrNapy1. 2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lan-2-yl)-9,9-dioctylfluorene (12) (0.5 mmol), 3,6-dibromo-9-
hexanecarbazole (9) (0.49 mmol), and 3,6-dibromo-9-(iridium-
(III)bis(2-(1′-naphthylpyridine-N,C2′))-9-(14-trifluoro-11,13-
tetradecyldiketone)carbazole (8b) (0.01 mmol) were used in the
1
polymerization. H NMR (CDCl3) δ (ppm): 8.52 (d, 2H), 7.86
PFCz. 2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
9,9-dioctylfluorene (12) (0.50 mmol) and 3,6-dibromo-9-hex-
anecarbazole (9) (0.50 mmol) were used in this polymerization.
1H NMR (CDCl3) δ (ppm): 8.52 (s, 2H), 7.84 (d, 2H), 7.79 (d,
2H) (fluorene ring), 7.72 (m, 2H), 7.53 (d, 2H), 7.24 (m, 2H)
(carbazole ring), 4.38 (s, 2H, N-CH2), 2.13 (d, 2H), 1.95 (t,
4H), 1.52-0.74 (m, 24 H) (aliphatic). 13C NMR (CDCl3) δ
(ppm): 151.69, 140.83, 140.40, 139.55, 133.09, 126.14, 123.63,
121.66, 119.87, 118.93, 109.04 (fluorene and carbazole ring),
56.94 (N9-carbazole ring), 55.34 (C9-fluorene ring), 40.62, 31.78,
31.62, 30.11, 29.23, 29.05, 27.02, 23.89, 22.57, 14.01 (aliphatic).
Anal. Calcd for (C29H40)50(C18H19N)50: C, 88.54; H, 9.26; N, 2.19;
Found: C, 88.03; H, 9.33; N, 1.88.
(t, 2H), 7.78 (m, 2H) (fluorene ring), 7.74 (d, 2H), 7.53 (t, 2H),
7.24 (s, 2H) (carbazole ring), 4.40 (s, 2H, N-CH2), 2.16 (t, 2H),
1.97 (m, 4H), 1.48-1.09 (m, 20), 0.93-0.76 (m, 16) (aliphatic).
13C NMR (CDCl3) δ (ppm): 151.72, 140.86, 140.42, 139.57,
133.11, 126.18, 125.54, 123.65, 121.69, 119.90, 118.97, 109.06
(fluorene and carbazole ring), 55.37 (C9-fluorene ring), 40.65,
31.81, 31.65, 30.12, 29.25, 29.08, 27.04, 23.92, 22.60, 14.03
(aliphatic). Anal. Calcd for (C29H40)50(C18H19N)49(C56H47N3F3O2-
Ir)1: C, 87.78; H, 9.12; N, 2.23. Found: C, 87.50; H, 9.46; N,
1.56.
PFCzIrNapy2. 2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lan-2-yl)-9,9-dioctylfluorene (12) (0.5 mmol), 3,6-dibromo-9-
hexanecarbazole (9) (0.48 mmol), and 3,6-dibromo-9-(iridium-
(III)bis(2-(1′-naphthylpyridine-N,C2′))-9-(14-trifluoro-11,13-
tetradecyldiketone)carbazole (8b) (0.02 mmol) were used in the
PFO. 2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
9,9-dioctylfluorene (12) (0.50 mmol) and 2,7-dibromo-9,9-
dioctylfluorene (11) (0.50 mmol) were used in this polymeri-
1
1
polymerization. H NMR (CDCl3) δ (ppm): 8.52 (s, 2H), 7.87
zation. H NMR (CDCl3) δ (ppm): 7.85 (d, 2H), 7.78 (s, 2H),
(d, 2H), 7.86 (d, 2H) (fluorene ring), 7.79 (m, 2H), 7.75 (d, 2H),
7.27 (s, 2H) (carbazole ring), 4.38 (s, 2H, N-CH2), 2.15 (t, 2H),
1.95 (t, 4H), 1.52-1.13 (m, 20H), 0.92-0.77 (m, 16H) (ali-
phatic). 13C NMR (CDCl3) δ (ppm): 151.69, 148.16, 140.84,
140.40, 139.55, 133.09, 126.17, 125.50, 123.63, 121.67, 119.88,
118.95, 109.04 (fluorene and carbazole ring), 55.35 (C9-fluorene
ring), 40.62, 31.79, 31.63, 30.10, 29.23, 29.06, 27.02, 23.90,
22.58, 14.09 (aliphatic). Anal. Calcd for (C29H40)50(C18H19N)48-
(C56H47N3F3O2Ir)2: C, 87.07; H, 8.99; N, 2.26. Found: C, 87.32;
H, 9.02; N, 1.99.
7.73 (d, 2H) (fluorene ring), 1.95 (m, 4H), 1.22-0.98 (m, 20H),
0.83 (t, 6H), 0.55 (m, 4H) (aliphatic). 13C NMR (CDCl3) δ
(ppm): 150.92, 144.52, 134.16, 129.31, 121.17, 119.84 (fluorene
ring), 55.58 (C9-fluorene ring), 40.42, 32.11, 30.27, 29.47, 25.24,
23.87, 22.86, 14.53 (aliphatic). Anal. Calcd for C29H40: C, 89.69;
H, 10.31. Found: C, 88.78; H, 9.63.
PFIrPiq05. 2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)-9,9-dioctyl-fluorene (12) (642 mg, 1.0 mmol), 3,6-dibromo-
9-(iridium(III) bis(1-phenylisoquinoline-N,C2′))-14-trifluoro-
11,13-tetradecyldiketone)carbazole (8a) (12 mg, 0.01 mmol),
and 2,7-dibromo-9,9-dioctylfluorene (11) (543 mg, 0.99 mmol)
PFCzIrPhq05. 2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lan-2-yl)-9,9-dioctylfluorene (12) (1.0 mmol), 3,6-dibromo-9-
hexanecarbazole (9) (0.99 mmol), and 3,6-dibromo-9-(iridium-
(III)bis(2-phenylquinoline-N,C2′))-14-trifluoro-11,13-tetradec-
yldiketone)carbazole (8c) (0.01 mmol) were used in this
1
were used in this polymerization. H NMR (CDCl3) δ (ppm):
8.52 (s, 2H), 7.84 (d, 2H), 7.79 (d, 2H) (fluorene ring), 2.13 (d,
2H), 1.95 (t, 4H), 1.52-0.74 (m, 24 H) (aliphatic). 13C NMR
(CDCl3) δ (ppm): 151.69, 139.55, 133.09, 126.14, 118.93, 109.04
(fluorene ring), 55.34 (C9-fluorene ring), 31.78, 31.62, 30.11,
29.23, 29.05, 27.02, 23.89, 22.57, 14.01 (aliphatic). Anal. Calcd
for (C29H40)99.5(C56H47N3F3O2Ir)0.5: C, 89.36; H, 10.23. Found:
C, 89.03; H, 9.53.
1
polymerization. H NMR (CDCl3) δ (ppm): 8.52 (s, 2H), 7.86
(d, 2H), 7.78 (t, 2H) (fluorene ring), 7.74 (m, 2H), 7.53 (d, 2H),
7.24 (s, 2H) (carbazole ring), 4.40 (s, 2H, N-CH2), 2.16 (t, 2H),
1.97 (t, 4H), 1.58-1.13 (m, 20H), 0.92-0.76 (m, 16H) (ali-
phatic). 13C NMR (CDCl3) δ (ppm): 151.72, 140.86, 140.42,
139.57, 133.11, 126.17, 125.55, 123.65, 121.69, 119.91, 118.96,
PFIrPhq2. 2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)-9,9-dioctylfluorene (12) (642 mg, 1.0 mmol), 3,6-dibromo-